Kidswell Bio Corporation (4584.T)
JPY 136.0
(18.26%)
JPY 136.0
(18.26%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -1.42 Billion JPY | -116.31% |
| 2022 | -657.43 Million JPY | -19.35% |
| 2021 | -550.86 Million JPY | 44.99% |
| 2020 | -1 Billion JPY | 86.31% |
| 2019 | -7.31 Billion JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -176.69 Million JPY | 73.81% |
| 2023 Q2 | -309.62 Million JPY | 34.21% |
| 2023 Q1 | -470.62 Million JPY | -1.76% |
| 2023 Q4 | -674.67 Million JPY | -2153.75% |
| 2023 Q3 | 32.85 Million JPY | 110.61% |
| 2023 FY | -1.42 Billion JPY | -116.31% |
| 2022 Q3 | -152.24 Million JPY | -497.84% |
| 2022 FY | -657.43 Million JPY | -19.35% |
| 2022 Q4 | -462.5 Million JPY | -203.8% |
| 2022 Q2 | 38.26 Million JPY | 0.0% |
| 2021 FY | -550.86 Million JPY | 44.99% |
| 2020 FY | -1 Billion JPY | 86.31% |
| 2019 FY | -7.31 Billion JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 384 Million JPY | 470.333% |
| PRISM BioLab Co.,LTD | -526.91 Million JPY | -169.888% |
| GNI Group Ltd. | 8.09 Billion JPY | 117.569% |
| Linical Co., Ltd. | 338.26 Million JPY | 520.402% |
| Trans Genic Inc. | 4.08 Million JPY | 34912.191% |
| MEDINET Co., Ltd. | -1.43 Billion JPY | 1.104% |
| Soiken Holdings Inc. | -662.2 Million JPY | -114.75% |
| Cytori Cell Research Institute, Inc. | 138.15 Million JPY | 1129.335% |
| AnGes, Inc. | -7.43 Billion JPY | 80.88% |
| OncoTherapy Science, Inc. | -1.28 Billion JPY | -10.398% |
| Nxera Pharma Co., Ltd. | -7.19 Billion JPY | 80.23% |
| Immuno-Biological Laboratories Co., Ltd. | 186.69 Million JPY | 861.716% |
| NanoCarrier Co., Ltd. | -780 Million JPY | -82.317% |
| Carna Biosciences, Inc. | -1.15 Billion JPY | -23.348% |
| CanBas Co., Ltd. | -1.2 Billion JPY | -17.624% |
| D. Western Therapeutics Institute, Inc. | -812.41 Million JPY | -75.044% |
| RaQualia Pharma Inc. | -323.66 Million JPY | -339.371% |
| Chiome Bioscience Inc. | -1.22 Billion JPY | -16.562% |
| PeptiDream Inc. | 3.03 Billion JPY | 146.843% |
| Oncolys BioPharma Inc. | -1.93 Billion JPY | 26.64% |
| Ribomic Inc. | -1.02 Billion JPY | -38.843% |
| SanBio Company Limited | -2.64 Billion JPY | 46.215% |
| Healios K.K. | -3.82 Billion JPY | 62.802% |
| BrightPath Biotherapeutics Co., Ltd. | -1.16 Billion JPY | -21.745% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.48 Billion JPY | 4.533% |
| Delta-Fly Pharma, Inc. | -1.42 Billion JPY | 0.512% |
| StemRIM | -2.02 Billion JPY | 29.67% |
| CellSource Co., Ltd. | 923.14 Million JPY | 254.048% |
| FunPep Company Limited | -933.41 Million JPY | -52.352% |
| Kringle Pharma, Inc. | -854.15 Million JPY | -66.49% |
| Stella Pharma Corporation | -763.74 Million JPY | -86.197% |
| TMS Co., Ltd. | -960.04 Million JPY | -48.127% |
| Noile-Immune Biotech Inc. | -1.13 Billion JPY | -25.846% |
| Cuorips Inc. | -632.18 Million JPY | -124.947% |
| K Pharma,Inc. | 260.33 Million JPY | 646.26% |
| Takara Bio Inc. | 1.48 Billion JPY | 196.086% |
| ReproCELL Incorporated | -31.41 Million JPY | -4426.748% |
| PhoenixBio Co., Ltd. | 26.37 Million JPY | 5491.152% |
| StemCell Institute Inc. | 310.98 Million JPY | 557.288% |
| Japan Tissue Engineering Co., Ltd. | 143.16 Million JPY | 1093.286% |
| CellSeed Inc. | -846.53 Million JPY | -67.988% |